Name (Synonyms) | Correlation | |
---|---|---|
drug141 | Algorithm-based recommendation Wiki | 1.00 |
drug2100 | Risk reduction Wiki | 1.00 |
drug1473 | Mesenchymal Stromal Cells Wiki | 0.58 |
drug2381 | Supportive Care Wiki | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.10 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.09 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The purpose of the current study is to test different interventions to determine the most effective way to promote flu vaccine uptake in a high-risk population identified by an "artificial intelligence" (AI) or machine learning (ML) algorithm. The specific aims are: 1. Evaluate the effect on flu vaccination rates of informing health-system patients who are identified by an ML analysis of EHR data to be at high risk for flu complications that they are at high risk with either (a) no additional explanation, (b) an explanation that this determination comes from an analysis of their medical records, and (c) the additional explanation that an AI or ML algorithm made this determination. 2. Evaluate the effects of the same three interventions on diagnoses of flu in the same patients.
Description: Patient received a flu vaccination
Measure: Flu vaccination rate Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Patient received a flu diagnosis
Measure: Flu diagnosis rate Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Patient was diagnosed with flu-like symptoms
Measure: Flu-like symptoms rate Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Patient was diagnosed with flu-related complications
Measure: Flu complications rate Time: Through 3 months after the end of the flu season (August 31st 2021), approximately 12 months assessment durationDescription: Number of patient visits to the ER, examining relative rate of visits across Time 1 and 2
Measure: Change in ER visits from pre- to post-intervention Time: Within 12 months pre-intervention (Time 1) and within 12 months post-intervention (Time 2)Description: Number of patient hospital visits, examining relative rate of visits across Time 1 and 2
Measure: Change in hospitalizations from pre- to post-intervention Time: Within 12 months pre-intervention (Time 1) and within 12 months post-intervention (Time 2)Description: Non-targeted fellow household members of targeted patients received a flu vaccination
Measure: Flu vaccination among fellow household members Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted fellow household members of targeted patients received a flu diagnosis
Measure: Flu diagnosis among fellow household members Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted fellow household members of targeted patients were diagnosed with flu-like symptoms
Measure: Flu-like symptoms among fellow household members Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted fellow household members of targeted patients were diagnosed with flu-related complications
Measure: Flu complications among fellow household members Time: Through 3 months after the end of the flu season (August 31st 2021), approximately 12 months assessment durationDescription: Non-targeted sub-threshold risk patients received a flu vaccination
Measure: Flu vaccination among those at sub-threshold risk Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted sub-threshold risk patients received a flu diagnosis
Measure: Flu diagnosis among those at sub-threshold risk Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted sub-threshold risk patients were diagnosed with flu-like symptoms
Measure: Flu-like symptoms among those at sub-threshold risk Time: Through the the end of the flu season (May 31st 2021), approximately 9 months assessment durationDescription: Non-targeted sub-threshold risk patients were diagnosed with flu-related complications
Measure: Flu complications among those at sub-threshold risk Time: Through 3 months after the end of the flu season (August 31st 2021), approximately 12 months assessment duration